Clomid 50mg/tab 50 Tabletten by Magnus Pharmaceuticals

Usage

1. Determine protocol start timing based on the half-life of the compounds used in the preceding cycle — allow sufficient washout before initiating clomiphene dosing to avoid competing androgen levels.
2. Begin the induction phase at 100 mg/day (two 50 mg tablets) on day one of PCT; take both tablets together or as split morning/evening doses based on individual GI tolerance.
3. Transition to the maintenance phase at week two: reduce to one 50 mg tablet daily, taken consistently at the same time each day to maintain stable plasma SERM levels.
4. Enter the taper phase at week four: split one 50 mg tablet into two halves and take one half (25 mg) daily — Magnus GMP compression uniformity supports accurate splitting.
5. Schedule bloodwork at the end of week four, assessing total testosterone, LH, and FSH; if values remain below baseline, discuss a two-week 25 mg extension with a qualified clinician before discontinuing.
6. After completing the final taper or extension week, discontinue clomiphene and continue monitoring hormonal markers at 30 and 60 days post-PCT to confirm sustained autonomous HPG axis function.

Warnings

Frequently asked questions

How should Clomiphene Citrate be dosed across the different phases of a PCT protocol?

A phase-structured approach starts with 100 mg/day (two tablets) for the first week to deliver peak LH/FSH stimulation, followed by 50 mg/day for weeks two and three to maintain gonadotropin elevation during testicular restoration, then 25 mg/day (one tablet split or half-tablet) in week four to wean the hypothalamus off SERM support. This graduated structure avoids abrupt hormonal swings at either end of the protocol.

Is it necessary to taper Clomiphene Citrate down at the end of PCT, or can you stop cold?

Tapering is strongly recommended. Abrupt cessation after several weeks of SERM-driven gonadotropin stimulation can produce a rapid drop in LH and FSH, risking a post-PCT hormonal dip. A final 25 mg/day week allows the hypothalamus to progressively reassume autonomous estrogen-feedback regulation, producing a gentler and more stable hormonal landing at the end of the protocol.

What factors determine how long a Clomiphene Citrate PCT protocol should run?

Protocol length is determined by the depth of suppression, the compounds used, and bloodwork response. A standard four-week tapered course covers most cases; however, if LH, FSH, and total testosterone remain below range at week-four blood testing, a clinician-guided two-week 25 mg extension is appropriate. The Magnus 50-tablet pack is sized to accommodate this extended option without an additional purchase.

Can Magnus Clomid 50mg tablets be split to achieve the 25mg taper dose?

Yes. Magnus Pharmaceuticals' GMP-controlled compression process and HPLC content-uniformity verification mean API distribution across the tablet is homogeneous, so splitting a 50 mg tablet yields two accurately proportional 25 mg doses suitable for the final taper phase. This eliminates the need to source a separate lower-dose product just for the weaning stage of the protocol.

What makes Magnus Pharmaceuticals Clomid at 50mg per tablet a practical choice compared to lower-concentration clomiphene formats?

At 50 mg per tablet — the highest per-unit concentration in this product group — Magnus Clomid requires fewer tablets during the induction and maintenance phases, simplifying daily dosing without pill-splitting. The 50-tab pack maps onto a full four-to-five-week tapered protocol with no surplus waste, while HPLC batch verification ensures the stated 50 mg dose is the confirmed delivered dose in every tablet. (2) angle_used

Manufacturer

Tablet formulation development at Magnus Pharmaceuticals is structured around the specific dosing requirements each compound places on the production process — and for Clomiphene Citrate 50 mg/tab, the central engineering focus is content uniformity across a high-API-per-unit oral solid. At 50 mg per tablet, distribution homogeneity during granulation and compression is the primary technical variable: validated mixing sequences and in-process tablet sampling at defined compression intervals ensure each unit achieves the target API load before batch release is granted. This approach to PCT-oriented tablet design reflects Magnus Pharmaceuticals' formulation philosophy that dosing precision is not a downstream quality check but an upstream process requirement built into the manufacturing sequence itself. Released batches carry HPLC-confirmed potency data and LAL endotoxin screening results as part of the lot documentation, providing analytical traceability for every pack of Clomid that leaves the facility.